Tridoss Laboratories Private Limited

Tridoss Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1981PTC025373 Incorporated 05 October 1981 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹38.05 Cr
▼ 13% YoY
Net profit · FY 2025
₹71.79 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹1.09 Cr
EBITDA margin 2.9%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.15 Cr
Issued & subscribed
Open charges
₹17.05 Cr
Secured borrowings
Company age
45 yrs
Est. 1981
Directors on board
2
As per MCA filings

About Tridoss Laboratories Private Limited

Data last updated:

Tridoss Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Caudilo Estate Development Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 October 1981 and has been in existence for over 45 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1981PTC025373. Its GSTIN is 27AAACT5011H1ZO (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.15 Cr. It was formerly known as Tridoss Laboratories Limited and Wockhardt Laboratories Pvt Ltd. It is led by directors Nargis Akhtar Shamsi and Akhtar Fakhruddin Shamsi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2nd Floor Room No 8167 Readymaoey Terrace Drannie Besant Rd Worli, Mumbai, Maharashtra, India – 400018.

As per the financials filed for FY 2025, the company reported a revenue of ₹38.05 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹71.79 Lakh (net margin 1.9%) and EBITDA of ₹1.09 Cr (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 38% over five years.

Its group structure includes 1 subsidiary.

As per MCA filings, the company has open charges of ₹17.05 Cr on record. Court records list 36 cases involving the company, including 22 filed by the company and 12 filed against it; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Tridoss Laboratories Private Limited
CIN U24230MH1981PTC025373
Registration Number 025373
Incorporation Date 05 October 1981
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Caudilo Estate Development Private Limited
Compliance Status Active Compliant

Name History of Tridoss Laboratories Private Limited

Tridoss Laboratories has undergone 3 name changes throughout its history. The company was previously known as Tridoss Laboratories Limited, Wockhardt Laboratories Pvt Ltd, and Panama Laboratories Pvt Ltd. The current legal name is Tridoss Laboratories Private Limited.

Company NameStatus
Tridoss Laboratories Private LimitedCurrent
Tridoss Laboratories LimitedPrevious
Wockhardt Laboratories Pvt LtdPrevious
Panama Laboratories Pvt LtdPrevious
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    2nd Floor Room No 8167 Readymaoey Terrace Drannie Besant Rd Worli, Mumbai, Maharashtra, India – 400018
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Tridoss Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Tridoss Laboratories Private Limited report

Financials, compliance, directors, charges, ownership and filings for Tridoss Laboratories Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Tridoss Laboratories Private Limited

The main business activity of Tridoss Laboratories is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Tridoss Laboratories Private Limited FY 2025 filings available

Tridoss Laboratories Private Limited reported revenue of ₹38.05 Cr (down 13% YoY) for FY 2025.

Revenue · FY 2025
₹38.05 Cr ▼ 13%
Net profit · FY 2025
₹71.79 Lakh margin 1.9%
EBITDA · FY 2025
₹1.09 Cr margin 2.9%

Compounded Annual Growth Rate (CAGR) of Tridoss Laboratories Private Limited

Revenue CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 7%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▼ 82%
3 years · compounded
▼ 43%
5 years · compounded
▲ 25%

Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Tridoss Laboratories Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.09 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹71.79 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Tridoss Laboratories Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.9%••••••••••••••••
Net Profit Margin1.9%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tridoss Laboratories are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Tridoss Laboratories Private Limited

Tridoss Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Peer Comparison of Tridoss Laboratories Private Limited

Tridoss Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Das Drugs Private Limited₹38.25 Cr (FY 2025)••••••••5.0%••••Llucknow, Uttar Pradesh, India
Hipra India Private Limited₹38.24 Cr (FY 2025)••••••••40.0%••••Pune, Maharashtra, India
Shree SSD Pharma Private Limited₹38.18 Cr (FY 2025)••••••••13.0%••••Nagpur, Maharashtra, India
Suman Medi Stores Private Limited₹38.14 Cr (FY 2024)••••••••19.0%••••Jhansi, Uttar Pradesh, India
Sreekara Medicine House Private Limited₹38.11 Cr (FY 2025)••••••••29.0%••••Vijayawada, Andhra Pradesh, India
Tridoss Laboratories Private Limited this company₹38.05 Cr (FY 2025)••••••••-13.0%••••Mumbai, Maharashtra, India
Evershine Pharmaceutical Distributors Private Limited₹37.9 Cr (FY 2024)••••••••9.0%••••Mumbai, Maharashtra, India
Spectrum Life Medical Devices Private Limited₹37.72 Cr (FY 2024)••••••••5.0%••••Ludhiana, Punjab, India
Agarwal Drug Distributors Private Limited₹37.64 Cr (FY 2025)••••••••2.0%••••Kolkata, West Bengal, India
Medi Basket Private Limited₹37.39 Cr (FY 2024)••••••••115.0%••••Indore, Madhya Pradesh, India
RMC Med Limited₹37.32 Cr (FY 2025)••••••••6.0%••••Jaipur, Rajasthan, India

Peers are the five companies nearest above and the five nearest below Tridoss Laboratories by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Tridoss Laboratories Private Limited

Tridoss Laboratories Private Limited is audited by J.L. Thakkar & Co. for the financial year 2023.

NameStatusAppointment DateCessation Date
J.L. Thakkar & Co.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Tridoss Laboratories Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Tridoss Laboratories Private Limited

Open charges
₹17.05 Cr
Satisfied charges
None
Breakdown by lending institutions
Standard Chartered Bank₹9.50 Cr
Banque Nationale De Paris₹6.00 Cr
The British Bank of the Middle Eat₹1.25 Cr
Dena Bank₹0.30 Cr
Latest charge details
DateLenderAmountStatus
19 Jun 1997Standard Chartered Bank₹9.5 CrOpen
22 Mar 1996Banque Nationale De Paris₹6 CrOpen
21 Jun 1993The British Bank of the Middle Eat₹1.25 CrOpen
19 Nov 1982Dena Bank₹30 LakhOpen

Total charge records: 4 View all charges

MSME Payment Delays by Tridoss Laboratories Private Limited

Tridoss Laboratories Private Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 202 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 14)

SupplierAmount dueDue sinceReported on
T S Logistic Solutions Private Limited••••••••••••
Shree Shyam Roadlink Private Limited••••••••••••
Medicef Pharma••••••••••••
Glide Chem Private Limited••••••••••••
Prochem Pharmaceuticals Private Limited••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 11 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Tridoss Laboratories Private Limited

Employment history and EPFO contributions of people linked to Tridoss Laboratories.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of Tridoss Laboratories Private Limited

Tridoss Laboratories has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key Subsidiaries
Company NameCINShares Held
Baruki Socks And Hosiery Private LimitedU17120MH1996PTC103652Locked

Showing major subsidiaries. Total: 1.

Recent Activity on Tridoss Laboratories Private Limited

Tridoss Laboratories Private Limited has 4 board changes on record since 2002: 2 appointments and 2 cessations. The latest: Akhtar Fakhruddin Shamsi ceased to be Director on 31 Jan 2019.

AGM
Tridoss Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Tridoss Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Akhtar Fakhruddin Shamsi ceased to be Director.
Ceased
Nargis Akhtar Shamsi ceased to be Director.
Appointed
Akhtar Fakhruddin Shamsi was appointed as Director.
Appointed
Nargis Akhtar Shamsi was appointed as Director.
Charges
A charge with Standard Chartered Bank amounted to Rs. 9.50 Cr with Charge ID 90188685 was registered on 19 Jun 1997.
Charges
A charge with Banque Nationale De Paris amounted to Rs. 6.00 Cr with Charge ID 90188642 was registered on 22 Mar 1996.
Charges
A charge with The British Bank Of The Middle Eat amounted to Rs. 1.25 Cr with Charge ID 90185946 was registered on 21 Jun 1993.
Charges
A charge with Dena Bank of Rs. 0.30 Cr registered on 19 Nov 1982 with Charge ID 90188120 was modified on 06 Sep 1985.
Charges
A charge with Dena Bank amounted to Rs. 0.30 Cr with Charge ID 90188120 was registered on 19 Nov 1982.
Incorporation
05 Oct 1981
Tridoss Laboratories Private Limited was registered on 05 Oct 1981 with Roc Mumbai I & aged 45 years 16 days as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Tridoss Laboratories Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Tridoss Laboratories Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Tridoss Laboratories Private Limited

Tridoss Laboratories has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AAACT5011H1ZOMaharashtraActive01 Jul 2017
06AAACT5011H1ZSHaryanaActive01 Jul 2020
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Tridoss Laboratories Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tridoss Laboratories Private Limited

Tridoss Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 October 1981 (45+ years old) and is registered under CIN U24230MH1981PTC025373.

Tridoss Laboratories reported revenue of ₹38.05 Cr for FY 2025 (down 13% YoY).

Tridoss Laboratories has 2 current directors:

Tridoss Laboratories reported a net profit of ₹71.79 Lakh (net margin 1.9%) and EBITDA of ₹1.09 Cr (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Tridoss Laboratories is -7% over three years and 38% over five years. In the latest year (FY 2025) revenue fell 13%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Tridoss Laboratories is 27AAACT5011H1ZO, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAACT5011H1ZS (Haryana).

The CIN (Corporate Identification Number) of Tridoss Laboratories is U24230MH1981PTC025373. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tridoss Laboratories has 36 court cases on record: 22 filed by the company and 12 filed against it. 2 are pending. Most are in the high courts.

Tridoss Laboratories was incorporated on 05 October 1981, making it 45+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Tridoss Laboratories by revenue are Das Drugs Private Limited, Hipra India Private Limited, Shree SSD Pharma Private Limited, Suman Medi Stores Private Limited, Sreekara Medicine House Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Akhtar Fakhruddin Shamsi ceased to be Director on 31 Jan 2019. Nargis Akhtar Shamsi ceased to be Director on 31 Jan 2019. Akhtar Fakhruddin Shamsi was appointed as Director on 02 Sep 2002. Tridoss Laboratories has 4 board changes on record in total.

Tridoss Laboratories has 11 MSME Form 1 returns on record between 2019 and 2023, listing 202 overdue payments to 14 micro and small suppliers. The latest return was filed on 30 Aug 2023.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available